Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abiomed, a provider of medical devices that provide circulatory support to acute heart failure patients, has completed public offering of 2.41 million shares of its common stock at $17.38 per share.
Subscribe to our email newsletter
The net proceeds to Abiomed from the offering were approximately $41.7 million, after deducting the underwriting discount and estimated offering expenses. Morgan Stanley & Co was the sole underwriter for the offering.